BUSINESS WIRE: Merck Completes € 180 Million Investment to Expand Schnelldorf Distribution Center

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

  • Expands facility by 25,000 square meters, nearly doubling size
  • Adds new down filling capabilities and distribution space for Life Science customers
  • Employs more than 470 people, including engineers, manufacturing and distribution experts

DARMSTADT, Germany --(BUSINESS WIRE)-- 06.06.2024 --

Merck, a leading science and technology company, has opened its newly expanded Life Science distribution center in Schnelldorf, Germany. The investment of € 180 million added 25,000 square meters to the site, almost doubling its size. It now includes a new manual down filling operation and additional space for the distribution of a wide range of products to laboratories and research facilities all around the world. The site employs 470 engineers, manufacturing and distribution experts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240606764930/en/

“By combining manual downing filling capabilities with our distribution expertise, our customers will benefit from increased product availability and quicker delivery,” said Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science. “This is critical to ensuring that medicines reach patients faster, safely, and more efficiently. This is how we do our part to impact life and health with science.”

'With this expansion, Schnelldorf is becoming one of our flagship sites, providing unique end-to-end capabilities for our Life Science customers' said Ivan Donzelot, Head of Integrated Supply Chain Operations, Life Science. “With the full integration of manufacturing and distribution in one site, our customers can now receive even faster and better service whether they are in Europe or in other regions of the world.”

The expansion of the Schnelldorf facility is part of a multi-year investment program of Merck’s Life Science business sector. It aims to increase the capacity and capabilities to support the growing global demand for critical drugs and to make significant contributions to public health. Since 2020, Merck has announced industrial capacity and capabilities expansion projects in Life Science throughout Europe, China, and the United States, of more than € 2 billion.

The Life Science Business of Merck is comprised of more than 50 production and testing sites and 64 distribution centers around the world and has more than 27,000 employees in 65 countries.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

Media Relations
Rachel Bloom Baglin
rachel.bloom-baglin@merckgroup.com
Phone: +49 (6151) 72-44461